deferoxamine has been researched along with ecallantide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amati, M; Botta, GC; Carmignani, M; Fubini, B; Governa, M; Valentino, M; VisonĂ , I; Volpe, AR | 1 |
Amati, M; Astolfi, P; Bolognini, L; Carlo Botta, G; Carmignani, M; Coloccini, S; Emanuelli, M; Fenoglio, I; Fubini, B; Governa, M; Pierella, F; Valentino, M; Volpe, AR | 1 |
2 other study(ies) available for deferoxamine and ecallantide
Article | Year |
---|---|
In vitro cleavage by asbestos fibers of the fifth component of human complement through free-radical generation and kallikrein activation.
Topics: Adult; Antidotes; Asbestos; Asbestos, Crocidolite; Asbestos, Serpentine; Carcinogens; Chelating Agents; Chemotaxis; Complement C5; Complement C5a; Deferoxamine; Enzyme Activation; Female; Free Radical Scavengers; Free Radicals; Humans; Male; Middle Aged; Plasma Kallikrein; Thiourea | 2000 |
Variability of biological effects of silicas: different degrees of activation of the fifth component of complement by amorphous silicas.
Topics: Aprotinin; Chemotaxis, Leukocyte; Complement C5; Complement C5a; Crystallization; Deferoxamine; Deoxyribose; Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Humans; Neutrophils; Oxidation-Reduction; Plasma Kallikrein; Silicon Dioxide; Spin Trapping; Thiourea; Zymosan | 2005 |